Patrick Weix, MD
Obstetrics & Gynecology · Dallas, TXNPI 1033103072
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,000 of the $95,635 with a category attached, or 82.6%. Applied Medical Resources Corporation accounts for 98.4% of it on its own, with 20 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $664.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$94K
- Medical Device Business Services, Inc.$325
- Davol Inc.$257
- Astellas Pharma US Inc$241
- Baxter Healthcare$148
- BD$93
- plus $465 from 15 others
What the payments were for
- Consulting fees$1,0131%
- Speaking & faculty fees$79,00083%
- Travel & lodging$11,74212%
- Food & beverage$3,5554%
- Education$3250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 108 | $94,106 |
| Medical Device Business Services, Inc. | 1 | $325 |
| Davol Inc. | 2 | $257 |
| Astellas Pharma US Inc | 8 | $241 |
| Baxter Healthcare | 1 | $148 |
| BD | 1 | $93 |
| AbbVie | 4 | $71 |
| Gynesonics, Inc. | 2 | $55 |
| Avion Pharmaceuticals | 2 | $41 |
| Mayne Pharma Commercial LLC | 2 | $36 |
| Meditrina | 2 | $36 |
| Olympus America Inc. | 1 | $36 |
| Exeltis, USA Inc. | 2 | $35 |
| Bayer | 1 | $32 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Millicent US Inc | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Insulet Corporation | 1 | $15 |
| Minerva Surgical, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$107,827
- PerClot$148
- GELPOINT VPATH$146
- ARISTA$143
- Veozah$115
- ARISTA AH FLEXITIP$114
How this compares
$95,635 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $3,414 |
| Norethindrone Acetate | 12 | $369 |
| Medroxyprogesterone Acetate | 11 | $220 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dallas
- Dale StovallDallas$590K
- Quanita CrableDallas$176K
- Kamilia SmithDallas$119K
- Yolanda LawsonDallas$96K
- David RogersDallas$44K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.